Navigation Links
FDA Clears AirStrip RPM for CRITICAL CARE & CARDIOLOGY Remote Patient Monitoring Solutions
Date:7/27/2010

SAN ANTONIO, July 27 /PRNewswire/ -- AirStrip Technologies, a pioneer in mobile medical software applications, today announced that it has received U.S. Food and Drug Administration (FDA) clearance to market the AirStrip Remote Patient Monitoring solution (RPM), including AirStrip RPM CRITICAL CARE and AirStrip RPM CARDIOLOGY.

(Photo:  http://photos.prnewswire.com/prnh/20100727/CG41710-a)

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100727/CG41710-a)

(Photo:  http://photos.prnewswire.com/prnh/20100727/CG41710-c)

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100727/CG41710-c)

(Photo:  http://photos.prnewswire.com/prnh/20100727/CG41710-d)

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100727/CG41710-d)

(Logo:  http://photos.prnewswire.com/prnh/20100727/CG41710LOGO-b)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100727/CG41710LOGO-b)

With FDA clearance in place, AirStrip now extends its virtual real time remote patient monitoring technology to a broad array of acute patient clinical settings, which include the intensive care unit, the emergency department, the operating room, the neonatal ICU, and virtually any other care environment.  

The AirStrip RPM solution allows clinicians unprecedented remote access to critical patient data in virtual real time. Medical professionals will use their smartphones to see vital signs, critical waveform data and other clinical information, which is sent directly from the hospital and can be accessed from virtually anywhere a cell-phone or other wireless connection is available.

The U.S. healthcare system is facing a core dilemma - an increasing discrepancy between the growing number of patients that need to be monitored and the decreasing number of doctors, nurses and other providers that are available to monitor them. This discrepancy is driving an urgent focus on telemedicine and solutions that can help medical professionals improve safety and overall care for patients when 'anytime, anywhere' access to critical data is needed.

The AirStrip RPM solution addresses this concern directly by delivering easy-to-use, standards-based, secure and intuitive mobile applications.  The power of the AirStrip technology, coupled with AirStrip's partners, will allow AirStrip to meet market demand on a global scale.

"With FDA clearance of the AirStrip RPM CRITICAL CARE and CARDIOLOGY solution, AirStrip has taken a giant step forward in an effort to improve patient safety, strengthen communication between medical professionals and affect better outcomes through the use of a growing suite of AirStrip solutions on mobile platforms," said Dr. Cameron Powell, President and CMO of AirStrip Technologies. "There are times when the physician simply cannot be at the bedside. However,  with the AirStrip RPM solution, multiple patients can be monitored virtually anywhere, anytime."

Initially developed for the Apple iPhone operating system, the AirStrip RPM CRITICAL CARE and CARDIOLOGY solutions will now be available to medical professionals who use the iPhone 3GS and iPhone 4, iPod touch, and the iPad. Dr. Powell said development of the expanded AirStrip RPM solutions for other smartphone brands is actively being pursued.

AirStrip Technologies released its first remote patient monitoring solution, AirStrip OB, in 2006. It remains the only solution of its kind available, and is now installed in labor and delivery units in more than 200 U.S. hospitals.

"The full potential of the AirStrip software development platform is being realized in our technical ability to leverage all that we have learned and accomplished with AirStrip OB into much broader clinical settings including the critical care and cardiology environments,"  said Trey Moore, CTO of AirStrip Technologies. "It allows us to very quickly meet changing market demands while still delivering cutting edge, native mobile software applications that deliver a rich user experience with a secure, fast mobile client."

"The FDA is taking great care to closely monitor the development of the rapidly evolving field of mobile healthcare applications," Dr. Powell added.  "The stringent federal regulatory submission process helps ensure that the AirStrip RPM solutions that are now going to market will be as safe and effective as possible."

Hospitals purchase the AirStrip system, which works in tandem with the hospital's existing patient monitoring and clinical information systems. Doctors can then install the application on their smartphone. To find out more about AirStrip RPM CRITICAL CARE and AirStrip RPM CARDIOLOGY, visit www.airstriptech.com.

About AirStrip Technologies, L.P.: Headquartered in San Antonio, Texas, AirStrip Technologies is a pioneer in mobile medical software applications designed to work across any platform to improve patient safety and reduce risk in the healthcare setting. AirStrip Technologies engages, consults and employs leading technology and medical experts to ensure their products are the best in the industry. The core technology team is committed to bringing best-of-breed products to the market that enhance the ability of physicians and healthcare professionals to perform their work on a daily basis with the added assurances that their patients are being provided the best care available. Visit www.airstriptech.com for more information.


'/>"/>
SOURCE AirStrip Technologies, L.P.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer
2. FDA Clears ExAblate Fertility Enhancement Study in Women With Uterine Fibroids
3. FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors
4. U.S. Food and Drug Administration Clears Way for Multi-Center Clinical Trial of IDEV Technologies SUPERA Peripheral Stent
5. FDA Clears a Test for Ovarian Cancer
6. Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group
7. U.S. Food and Drug Administration Clears Alcatel-Lucent Remote Patient Monitoring Solution for Sale in the United States
8. FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets
9. FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology
10. FDA Clears the Fenwal Amicus(R) Separator System for Collecting Platelets in New Additive Solution
11. FDA Clears Three Additional Antimicrobials for Use on TREK Sensititre(R) In Vitro Diagnostic (IVD) MIC Susceptibility Plates: Minocycline and Telavancin Used to Treat MRSA and Other Infections; and Tigecycline, Now Cleared for Streptococcus Pneumoni
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)...  NDS received FDA 510(k) clearance in May 2017 for its ... specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... to support the improvement of patient outcomes, procedural efficiency, and the ... ... ...
(Date:10/4/2017)... , Oct. 4, 2017  According to the Centers for Disease Control ... of October . PhysicianOne Urgent Care is helping communities across ... NY , by offering no-cost* flu shots through the end of ... by certain health insurance regulations. ... best time to get a flu shot is by the end of ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):